Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C. Yaeger R, Weiss J, Pelster MS, Spira AI, et al. N Engl J Med 2022 Dec 21. doi: 10.1056/NEJMoa2212419.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yaeger R, Weiss J, Pelster MS, Spira AI, et al. Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C. N Engl J Med 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
PMID: 36546659